Novo Nordisk Launches Daily Weight-Loss Pill to Expand GLP-1 Access

A daily pill for weight loss has officially arrived in the U.S. On Monday, Novo Nordisk rolled out the first GLP-1 weight-loss pill, an oral version of Wegovy. The company says the new option is ...

Methyl Acetate Market worth $388.5 million by 2030, at a CAGR of 7.9%, says ...

The Methyl Acetate Market is expected to reach USD 388.5 million by 2030 from USD 228.0 million in 2025, at a CAGR of 7.9% ...

Early-Stage Victory: How Defense Strategy Defeated Securities Class Action Against HUMBL

Complex securities class actions rarely end quickly, but when fundamental legal requirements remain unmet despite multiple attempts, even the most determined plaintiff effort can collapse at the ...